Aside from controlling what happens leading up to my death, I've given a lot of thought and put the wheels in motion for what will happen to me after I die.
Amanda L. Kong, discusses why patients should consider seeking a second opinion for their breast cancer diagnosis and care at a high volume hospital.
Barbara Van Husen, president of the MPN Research Foundation, discusses how after the discovery of the JAK2 mutation in 2005, MPN research and treatment advances proliferated. Now, Van Husen says, it is one of the most active areas of hematological research
Researchers should not give up hope in using immunotherapy to treat brain cancers.
An expert from John Theurer Cancer Center shares three recipes to help fight winter’s germs.
Lack of insurance is one of the greatest barriers to access to health care.
We were honored to present an annual evening of celebration and appreciation for the heroes that have made a difference in the lives of individuals living with multiple myeloma.
“I was a senior in high school when my father was diagnosed, so I became his caregiver while my mother worked. All of that is what drove me to where I am today," an oncology nurse explained.
Mindy Mintz Mordecai, founder, president, and CEO of the Esophageal Cancer Action Network (ECAN), discusses the link between acid reflux and esophageal cancer.
Disparities in lung cancer care must be closed to improve patient outcomes.
An Extraordinary Healer essay honoring Pat Brown, RN [ Clearview Cancer Institute in Huntsville, Alabama ]
Writing poetry has helped me process all that I've been through as a breast cancer survivor.
As a plastic surgeon, patient safety is my top priority. I want anyone with breast implants to be aware of a recent recall linked to a rare lymphoma that may affect them.
Should cancers that are not traditionally associated with Lynch syndrome or MSI-H status be tested? This expert thinks so.
The 17th international Thyroid Cancer Survivors' Conference will be held Oct. 17 to 19, 2014 in Denver.
Dr. Omid Hamid discusses combining targeted drugs and immunotherapy, the role of surgery and ongoing research efforts in melanoma.
With the overall number of deaths from cancer in decline over the past 20 years, advocacy groups like the National Ovarian Cancer Coalition are doing their part to reduce this number further.
Because they have been found to be effective in the treatment of many types of cancer, including melanoma, immunotherapy drugs like anti-PD-1 agents and anti-CTLA4 therapies should not be discounted because of their toxicities.
The side effects of colorectal cancer and its treatment—which span beyond fertility issues—require constant renegotiation and reframing of what it means to be me.
An Extraordinary Healer Essay honoring Karen Ebert, BSN, RN, OCN [ Trinitas Comprehensive Cancer Center in Elizabeth, New Jersey ]
It is important that patients and their loved ones stay hopeful during the ovarian cancer journey. We asked attendees of the 2018 NOCC Annual Conference how they keep positive.